Unique dermatological complication of rhM-CSF treatment.
A patient is presented who developed cutaneous papular histiocytic infiltrates after treatment with monocyte colony stimulating factor (rhM-CSF). This is the first reported complication of this type after treatment with this new cytokine.
Dutcher
J P
JP
Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10467.
Benchabbat
A
A
Jones
J G
JG
Wiernik
P H
PH
D006801:Humans; D007262:Infusions, Intravenous; D016173:Macrophage Colony-Stimulating Factor / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
D011994:Recombinant Proteins; D016173:Macrophage Colony-Stimulating Factor